Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity
- PMID: 16670248
- DOI: 10.1097/01.JGP.0000218218.47279.db
Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity
Abstract
Objectives: The objectives of this study were to describe the prevalence of neuropsychiatric symptoms of dementia in Alzheimer disease (AD) and cognitively impaired nondemented (CIND) subjects from a community-based Brazilian sample and to correlate these symptoms with severity of cognitive deficits.
Method: A total of 1,563 randomly selected subjects were evaluated with the following screening tests: Mini-Mental Status Examination, Fuld Object Memory Evaluation, Informant Questionnaire on Cognitive Decline in the Elderly, and Activities of Daily Living-International Scale. Screen positives were submitted to a workup for dementia, physical and neurologic examination, cranial computed tomography or cerebral magnetic resonance imaging, the Cambridge Examination for Mental Disorders, Clinical Dementia Rating Scale (CDR), and the Neuropsychiatric Inventory (NPI). Diagnosis was made according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria.
Results: Sixty patients with AD, 25 CIND, and 78 healthy elderly subjects were evaluated. Informants reported that 78.33% of patients with AD had one or more neuropsychiatric symptoms. Apathy (53.33%), depression (38.33%), sleep alterations (38.33%), and anxiety (25%) were the most prevalent disturbances in AD subjects. These disturbances were more prevalent in patients with AD than in the comparison group and CIND individuals. In the CIND group, the most frequent neuropsychiatric symptoms were anxiety and sleep alterations (both with 24%) followed by depression (16%). Total NPI scores were significantly different between AD and CIND groups, AD and comparison groups, and CIND and the comparison group. Apathy was the only neuropsychiatric symptom that was significantly different between the groups divided according to the CDR being more frequent in subjects with moderate to severe dementia.
Conclusions: Neuropsychiatric symptoms seem to be as common in patients living in a developing country as they are in demented patients from the developed world. Indeed, the fact that some of our results are similar to other population-based studies may suggest that cultural factors play a minor role in the emergence of these symptoms, at least in a Latin American country like Brazil.
Similar articles
-
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.Curr Alzheimer Res. 2010 Sep;7(6):517-26. doi: 10.2174/156720510792231748. Curr Alzheimer Res. 2010. PMID: 20455862
-
Correlation between neuropsychiatric symptoms and caregiver burden in a population-based sample from São Paulo, Brazil: a preliminary report.Dement Neuropsychol. 2013 Jul-Sep;7(3):258-262. doi: 10.1590/S1980-57642013DN70300005. Dement Neuropsychol. 2013. PMID: 29213848 Free PMC article.
-
[A preliminary study on the Korean version of quality of life-Alzheimer's disease (QOL-AD) scale in community-dwelling elderly with dementia].J Prev Med Public Health. 2006 May;39(3):243-8. J Prev Med Public Health. 2006. PMID: 16764499 Korean.
-
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.Dement Geriatr Cogn Disord. 2007;24(6):457-63. doi: 10.1159/000110738. Epub 2007 Nov 7. Dement Geriatr Cogn Disord. 2007. PMID: 17986816 Review.
-
Neuropsychiatric assessment of Alzheimer's disease and related dementias.Aging (Milano). 2001 Jun;13(3):240-6. doi: 10.1007/BF03351482. Aging (Milano). 2001. PMID: 11444257 Review.
Cited by
-
Epidemiology and management of apathy in patients with Alzheimer's disease.Drugs Aging. 2007;24(7):547-54. doi: 10.2165/00002512-200724070-00003. Drugs Aging. 2007. PMID: 17658906 Review.
-
Frontotemporal dementia to Alzheimer's disease.Dialogues Clin Neurosci. 2007;9(2):153-60. doi: 10.31887/DCNS.2007.9.2/msilveri. Dialogues Clin Neurosci. 2007. PMID: 17726914 Free PMC article. Review.
-
Behavioral and psychological symptoms in dementia is not a unitary concept: A critical review with emphasis on Alzheimer's disease.Dement Neuropsychol. 2008 Oct-Dec;2(4):272-277. doi: 10.1590/S1980-57642009DN20400007. Dement Neuropsychol. 2008. PMID: 29213584 Free PMC article.
-
Apathy, cognitive function and motor function in Alzheimer's disease.Dement Neuropsychol. 2012 Oct-Dec;6(4):236-243. doi: 10.1590/S1980-57642012DN06040007. Dement Neuropsychol. 2012. PMID: 29213803 Free PMC article.
-
Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).Am J Geriatr Psychiatry. 2013 Jun;21(6):549-59. doi: 10.1016/j.jagp.2012.12.018. Epub 2013 Jan 18. Am J Geriatr Psychiatry. 2013. PMID: 23567407 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical